Incorporating efficacy data from initial trials into subsequent evaluations: Application to vaccines against respiratory syncytial virus is a research paper published in medRxiv (2023). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
National Institutes of Health
Grant: 1R01AI137093-01A1
Predicting and monitoring variations in the effects of vaccines against RSV
National Institutes of Health
Grant: 3UL1TR001863-08S1
Yale Clinical and Translational Science Award: Nwanaji-Enwerem Diversity in Health Related Research
NIAID NIH HHS
Grant: R01 AI137093
NCATS NIH HHS
Grant: UL1 TR001863
Fields of Study
Keywords
Sustainable Development Goals